BBC
NYSE
$49.74
VIRTUS BIOTECH CLINICAL TRIALS ETF (BBC)
Sector:
Healthcare
Industry:
Biotechnology
Net assets
$53M
Inception date
December 16, 2014
Expense ratio
0.65%
Sharpe Ratio
2.40
Price Chart
Valuation
Net assets$53M
P/S16.89
P/B3.80
Profitability
Profit Margin-13.4%
Operating Margin-3923%
Financial Health
Debt-to-Equity0.7%
Growth & Risk
FCF 5Y CAGR+28.83%
Beta (5Y)1.19
Sharpe Ratio2.40